Tired of seasonal coughs and stuffy noses?

The Gemini Study is trying to protect people 60 years of age or older from viruses that cause common cold-like symptoms. Researchers want to see if a potential new (investigational) vaccine can protect you from respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).

RSV/Pneumonia Vaccine Study Interest Form

Name(Required)

First Last

Email(Required)

Phone(Required)

Date of Birth(Required)

Participants in this study must be at least 60-years-old.

How would you describe yourself?*

Alaska Native

American Indian

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White

Hispanic or Latino or Spanish Origin

Prefer Not to Say

*Please check all that apply.

CAPTCHA

Comments

This field is for validation purposes and should be left unchanged.

About the Study

The Gemini study plans to enroll a variety of people because vaccines may affect people differently based on their age, gender, race, and ethnicity.

What is required?

The study will last for about 2 years. Study injections will take place right before or during the start of the RSV/hMPV season. You will receive 1 injection of the investigational vaccine being studied or a placebo each year. A placebo does not contain any actual vaccine.

Who can Participate?

You may be able to take part if you:

are 60 years of age or older
agree to attend study site visits.